High incidence of mild acute mountain sickness in conference attendees at 10 000 foot altitude
- 1 May 1990
- journal article
- Published by SAGE Publications in Journal of Wilderness Medicine
- Vol. 1 (2) , 86-92
- https://doi.org/10.1580/0953-9859-1.2.86
Abstract
An epidemic of mild acute mountain sickness (AMS) occurred at a 4-day meeting of epidemiologists held at an altitude of 3000 m (9800 ft) in the Rocky Mountains of Colorado, USA. Questionnaires from 96% of the 105 attendees documented the following symptom frequencies: headache, 59%; shortness of breath, 59%; difficulty in sleeping, 45%; weakness or dizziness, 40%; and nausea, 12%. AMS, defined as three or more symptoms, occurred in 42% of the respondents, and 90% had at least one symptom. One third felt the illness interfered with their concentration at the meeting, and 31% would not plan another meeting at this altitude, although only one person missed meeting sessions as a result of the AMS. AMS should be anticipated by those planning meetings of short duration at high altitude, and by physicians advising travelers to altitudes over 2000 m.Keywords
This publication has 9 references indexed in Scilit:
- CARBON DIOXIDE BREATHING AND MOUNTAIN SICKNESSThe Lancet, 1989
- Acute Mountain SicknessNew England Journal of Medicine, 1988
- EFFECT OF CARBON DIOXIDE IN ACUTE MOUNTAIN SICKNESS: A REDISCOVERYThe Lancet, 1988
- A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxisThe American Journal of Medicine, 1987
- Acetazolamide in acute mountain sickness.BMJ, 1987
- Successful treatment of acute mountain sickness with dexamethasone.BMJ, 1987
- Acute Mountain Sickness and AcetazolamideJAMA, 1982
- THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESSThe Lancet, 1976
- Effect of Acetazolamide on Acute Mountain SicknessNew England Journal of Medicine, 1968